KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 50 filers reported holding KEROS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,051,793 | +59.9% | 44,897 | +131.7% | 0.00% | – |
| Q1 2024 | $1,282,890 | +66.2% | 19,379 | -0.2% | 0.00% | – |
| Q4 2023 | $772,020 | +128.3% | 19,417 | +83.1% | 0.00% | – |
| Q3 2023 | $338,119 | -33.0% | 10,606 | -15.6% | 0.00% | – |
| Q2 2023 | $504,902 | -37.9% | 12,566 | -34.0% | 0.00% | – |
| Q1 2023 | $813,093 | -11.7% | 19,042 | -42.9% | 0.00% | – |
| Q2 2022 | $921,000 | -35.4% | 33,356 | +27.3% | 0.00% | – |
| Q1 2022 | $1,425,000 | +265.4% | 26,200 | +152.0% | 0.00% | – |
| Q2 2020 | $390,000 | – | 10,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |